Christopher Shelton

Company: GlaxoSmithKline
Job title: Scientific Director, Tumor Cell Targeting Research Unit
Seminars:
Strategies to Maximize the Effectiveness of Belantamab Mafodotin 9:30 am
Leveraging antibody effector functions in combination with cytotoxic payloads Discussing manipulation of cell surface levels of target to maximize potency Examining the effect of DAR on efficacyRead more
day: Day Two